JCB logo
IN Cell Analyzer 2000
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 10 July 2000.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 285K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ackerley, S.
Right arrow Articles by Miller, C. C.J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Ackerley, S.
Right arrow Articles by Miller, C. C.J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

© The Rockefeller University Press, 0021-9525/2000//165 $5.00
The Journal of Cell Biology, Volume 150, Number 1, , 2000 165-176


Original Article

Glutamate Slows Axonal Transport of Neurofilaments in Transfected Neurons



Steven Ackerleya,b, Andrew J. Griersona,b, Janet Brownleesa,b, Paul Thornhilla,b, Brian H. Andertona, P. Nigel Leighb, Christopher E. Shawb, and Christopher C.J. Millera,b

a Department of Neuroscience, The Institute of Psychiatry, Kings College London, London SE5 8AF United Kingdom
b Department of Neurology, The Institute of Psychiatry, Kings College London, London SE5 8AF United Kingdom
Department of Neuroscience, The Institute of Psychiatry, Denmark Hill, London SE5 8AF UK.2-07-848-0393

Neurofilaments are transported through axons by slow axonal transport. Abnormal accumulations of neurofilaments are seen in several neurodegenerative diseases, and this suggests that neurofilament transport is defective. Excitotoxic mechanisms involving glutamate are believed to be part of the pathogenic process in some neurodegenerative diseases, but there is currently little evidence to link glutamate with neurofilament transport. We have used a novel technique involving transfection of the green fluorescent protein–tagged neurofilament middle chain to measure neurofilament transport in cultured neurons. Treatment of the cells with glutamate induces a slowing of neurofilament transport. Phosphorylation of the side-arm domains of neurofilaments has been associated with a slowing of neurofilament transport, and we show that glutamate causes increased phosphorylation of these domains in cell bodies. We also show that glutamate activates members of the mitogen-activated protein kinase family, and that these kinases will phosphorylate neurofilament side-arm domains. These results provide a molecular framework to link glutamate excitotoxicity with neurofilament accumulation seen in some neurodegenerative diseases.

Key Words: neurofilament proteins • phosphorylation • amyotrophic lateral sclerosis • Alzheimer's disease



© 2000 The Rockefeller University Press

S. Ackerley and A.J. Grierson contributed equally to this work.

Abbreviations used in this paper: ALS, amyotrophic lateral sclerosis; cdk5, cyclin-dependent kinase 5; EGFP, enhanced green fluorescent protein; GST, glutathione-S-transferase; MAPK, mitogen-activated protein kinase; MPR, multiphosphorylation repeat; NF-H, neurofilament heavy chain; NF-L, neurofilament light chain; NF-M, neurofilament middle chain; SAPK, stress-activated protein kinase.



Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents